Skip to main content
Erschienen in: Journal of Nuclear Cardiology 1/2022

11.06.2020 | ORIGINAL ARTICLE

Observer repeatability and interscan reproducibility of 18F-sodium fluoride coronary microcalcification activity

verfasst von: Evangelos Tzolos, MD, Jacek Kwiecinski, MD, PhD, Martin Lyngby Lassen, PhD, Sebastien Cadet, MS, Philip D. Adamson, MD, PhD, Alastair J. Moss, MD, PhD, Nikhil Joshi, MD, PhD, Michelle C. Williams, MD, PhD, Edwin J. R. van Beek, MD, PhD, Damini Dey, PhD, Daniel S. Berman, MD, Marc R. Dweck, MD, PhD, David E. Newby, MD, PhD, Piotr J. Slomka, PhD

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

We aimed to establish the observer repeatability and interscan reproducibility of coronary 18F-sodium-fluoride positron emission tomography (PET) uptake using a novel semi-automated approach, coronary microcalcification activity (CMA).

Methods

Patients with multivessel coronary artery disease underwent repeated hybrid PET and computed tomography angiography (CTA) imaging (PET/CTA). CMA was defined as the integrated standardized uptake values (SUV) in the entire coronary tree exceeding 2 standard deviations above the background SUV. Coefficients of repeatability between the same observer (intraobserver repeatability), between 2 observers (interobserver repeatability) and coefficient of reproducibility between 2 scans (interscan reproducibility), were determined at vessel and patient level.

Results

In 19 patients, CMA was assessed twice in 43 coronary vessels on two PET/CT scans performed 12 ± 5 days apart. There was excellent intraclass correlation for intraobserver and interobserver repeatability as well as interscan reproducibility (all ≥ 0.991). There was 100% intraobserver, interobserver and interscan agreement for the presence (CMA > 0) or absence (CMA = 0) of coronary18F-NaF uptake. Mean CMA was 3.12 ± 0.62 with coefficients of repeatability of ≤ 10% for all measures: intraobserver 0.24 and 0.22, interobserver 0.30 and 0.29 and interscan 0.33 and 0.32 at a per-vessel and per-patient level, respectively.

Conclusions

CMA is a repeatable and reproducible global measure of coronary atherosclerotic activity.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Irkle A, Vesey AT, Lewis DY, Skepper JN, Bird JL, Dweck MR, et al. Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat Commun 2015;6:7495.PubMedCrossRef Irkle A, Vesey AT, Lewis DY, Skepper JN, Bird JL, Dweck MR, et al. Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat Commun 2015;6:7495.PubMedCrossRef
2.
Zurück zum Zitat Creager MD, Hohl T, Hutcheson JD, Moss AJ, Schlotter F, Blaser MC, et al. (18)F-fluoride signal amplification identifies microcalcifications associated with atherosclerotic plaque instability in positron emission tomography/computed tomography images. Circ Cardiovasc Imaging 2019;12:e007835.PubMedPubMedCentralCrossRef Creager MD, Hohl T, Hutcheson JD, Moss AJ, Schlotter F, Blaser MC, et al. (18)F-fluoride signal amplification identifies microcalcifications associated with atherosclerotic plaque instability in positron emission tomography/computed tomography images. Circ Cardiovasc Imaging 2019;12:e007835.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Dweck MR, Chow MW, Joshi NV, Williams MC, Jones C, Fletcher AM, et al. Coronary arterial 18F-sodium fluoride uptake: A novel marker of plaque biology. J Am Coll Cardiol 2012;59:1539-48.PubMedCrossRef Dweck MR, Chow MW, Joshi NV, Williams MC, Jones C, Fletcher AM, et al. Coronary arterial 18F-sodium fluoride uptake: A novel marker of plaque biology. J Am Coll Cardiol 2012;59:1539-48.PubMedCrossRef
4.
Zurück zum Zitat Dweck MR, Jenkins WS, Vesey AT, Pringle MA, Chin CW, Malley TS, et al. 18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis. Circ Cardiovasc Imaging 2014;7:371-8.PubMedCrossRef Dweck MR, Jenkins WS, Vesey AT, Pringle MA, Chin CW, Malley TS, et al. 18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis. Circ Cardiovasc Imaging 2014;7:371-8.PubMedCrossRef
5.
Zurück zum Zitat Massera D, Trivieri MG, Andrews JPM, Sartori S, Abgral R, Chapman AR, et al. Disease activity in mitral annular calcification. Circ Cardiovasc Imaging 2019;12:e008513.PubMedPubMedCentralCrossRef Massera D, Trivieri MG, Andrews JPM, Sartori S, Abgral R, Chapman AR, et al. Disease activity in mitral annular calcification. Circ Cardiovasc Imaging 2019;12:e008513.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Cartlidge TRG, Doris MK, Sellers SL, Pawade TA, White AC, Pessotto R, et al. Detection and prediction of bioprosthetic aortic valve degeneration. J Am Coll Cardiol. 2019;73:1107–19.PubMedPubMedCentralCrossRef Cartlidge TRG, Doris MK, Sellers SL, Pawade TA, White AC, Pessotto R, et al. Detection and prediction of bioprosthetic aortic valve degeneration. J Am Coll Cardiol. 2019;73:1107–19.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Joshi NV, Vesey AT, Williams MC, Shah AS, Calvert PA, Craighead FH, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: A prospective clinical trial. Lancet 2014;383:705-13.PubMedCrossRef Joshi NV, Vesey AT, Williams MC, Shah AS, Calvert PA, Craighead FH, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: A prospective clinical trial. Lancet 2014;383:705-13.PubMedCrossRef
8.
Zurück zum Zitat Kwiecinski J, Cadet S, Daghem M, Lassen ML, Dey D, Dweck MR, et al. Whole-vessel coronary (18)F-sodium fluoride PET for assessment of the global coronary microcalcification burden. Eur J Nucl Med Mol Imaging 2020;47:1736-45.PubMedPubMedCentralCrossRef Kwiecinski J, Cadet S, Daghem M, Lassen ML, Dey D, Dweck MR, et al. Whole-vessel coronary (18)F-sodium fluoride PET for assessment of the global coronary microcalcification burden. Eur J Nucl Med Mol Imaging 2020;47:1736-45.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Kwiecinski J, Dey D, Cadet S, Lee SE, Tamarappoo B, Otaki Y, et al. Predictors of 18F-sodium fluoride uptake in patients with stable coronary artery disease and adverse plaque features on computed tomography angiography. Eur Heart J Cardiovasc Imaging 2020;21:58-66.PubMedCrossRef Kwiecinski J, Dey D, Cadet S, Lee SE, Tamarappoo B, Otaki Y, et al. Predictors of 18F-sodium fluoride uptake in patients with stable coronary artery disease and adverse plaque features on computed tomography angiography. Eur Heart J Cardiovasc Imaging 2020;21:58-66.PubMedCrossRef
10.
Zurück zum Zitat Kwiecinski J, Slomka PJ, Dweck MR, Newby DE, Berman DS. Vulnerable plaque imaging using 18F-sodium fluoride positron emission tomography. Br J Radiol 2019:20190797. Kwiecinski J, Slomka PJ, Dweck MR, Newby DE, Berman DS. Vulnerable plaque imaging using 18F-sodium fluoride positron emission tomography. Br J Radiol 2019:20190797.
11.
Zurück zum Zitat Moss AJ, Doris MK, Andrews JPM, Bing R, Daghem M, van Beek EJR, et al. Molecular coronary plaque imaging using (18)F-fluoride. Circ Cardiovasc Imaging 2019;12:e008574.PubMedPubMedCentralCrossRef Moss AJ, Doris MK, Andrews JPM, Bing R, Daghem M, van Beek EJR, et al. Molecular coronary plaque imaging using (18)F-fluoride. Circ Cardiovasc Imaging 2019;12:e008574.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Kitagawa T, Yamamoto H, Nakamoto Y, Sasaki K, Toshimitsu S, Tatsugami F, et al. Predictive value of (18)F-sodium fluoride positron emission tomography in detecting high-risk coronary artery disease in combination with computed tomography. J Am Heart Assoc 2018;7:e010224.PubMedPubMedCentralCrossRef Kitagawa T, Yamamoto H, Nakamoto Y, Sasaki K, Toshimitsu S, Tatsugami F, et al. Predictive value of (18)F-sodium fluoride positron emission tomography in detecting high-risk coronary artery disease in combination with computed tomography. J Am Heart Assoc 2018;7:e010224.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Lassen ML, Kwiecinski J, Dey D, Cadet S, Germano G, Berman DS, et al. Triple-gated motion and blood pool clearance corrections improve reproducibility of coronary (18)F-NaF PET. Eur J Nucl Med Mol Imaging 2019;46:2610-20.PubMedPubMedCentralCrossRef Lassen ML, Kwiecinski J, Dey D, Cadet S, Germano G, Berman DS, et al. Triple-gated motion and blood pool clearance corrections improve reproducibility of coronary (18)F-NaF PET. Eur J Nucl Med Mol Imaging 2019;46:2610-20.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Chen W, Dilsizian V. PET assessment of vascular inflammation and atherosclerotic plaques: SUV or TBR? J Nucl Med 2015;56:503-4.PubMedCrossRef Chen W, Dilsizian V. PET assessment of vascular inflammation and atherosclerotic plaques: SUV or TBR? J Nucl Med 2015;56:503-4.PubMedCrossRef
15.
Zurück zum Zitat Blomberg BA, Bashyam A, Ramachandran A, Gholami S, Houshmand S, Salavati A, et al. Quantifying [18F]fluorodeoxyglucose uptake in the arterial wall: The effects of dual time-point imaging and partial volume effect correction. European Journal of Nuclear Medicine and Molecular Imaging 2015;42:1414-22.PubMedCrossRef Blomberg BA, Bashyam A, Ramachandran A, Gholami S, Houshmand S, Salavati A, et al. Quantifying [18F]fluorodeoxyglucose uptake in the arterial wall: The effects of dual time-point imaging and partial volume effect correction. European Journal of Nuclear Medicine and Molecular Imaging 2015;42:1414-22.PubMedCrossRef
16.
Zurück zum Zitat Moss AJ, Dweck MR, Doris MK, Andrews JPM, Bing R, Forsythe RO et al. Ticagrelor to reduce myocardial injury in patients with high-risk coronary artery plaque. JACC Cardiovasc Imaging 2019;S1936-878X(19)30557-1. Moss AJ, Dweck MR, Doris MK, Andrews JPM, Bing R, Forsythe RO et al. Ticagrelor to reduce myocardial injury in patients with high-risk coronary artery plaque. JACC Cardiovasc Imaging 2019;S1936-878X(19)30557-1.
17.
Zurück zum Zitat Rubeaux M, Joshi NV, Dweck MR, Fletcher A, Motwani M, Thomson LE, et al. Motion correction of 18F-NaF PET for imaging coronary atherosclerotic plaques. J Nucl Med 2016;57:54-9.PubMedCrossRef Rubeaux M, Joshi NV, Dweck MR, Fletcher A, Motwani M, Thomson LE, et al. Motion correction of 18F-NaF PET for imaging coronary atherosclerotic plaques. J Nucl Med 2016;57:54-9.PubMedCrossRef
18.
Zurück zum Zitat Kwiecinski J, Adamson PD, Lassen ML, Doris MK, Moss AJ, Cadet S, et al. Feasibility of coronary (18)F-sodium fluoride positron-emission tomography assessment with the utilization of previously acquired computed tomography angiography. Circ Cardiovasc Imaging 2018;11:e008325.PubMedPubMedCentralCrossRef Kwiecinski J, Adamson PD, Lassen ML, Doris MK, Moss AJ, Cadet S, et al. Feasibility of coronary (18)F-sodium fluoride positron-emission tomography assessment with the utilization of previously acquired computed tomography angiography. Circ Cardiovasc Imaging 2018;11:e008325.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Kwiecinski J, Berman DS, Lee SE, Dey D, Cadet S, Lassen ML, et al. Three-hour delayed imaging improves assessment of coronary (18)F-Sodium Fluoride PET. J Nucl Med 2019;60:530-5.PubMedPubMedCentralCrossRef Kwiecinski J, Berman DS, Lee SE, Dey D, Cadet S, Lassen ML, et al. Three-hour delayed imaging improves assessment of coronary (18)F-Sodium Fluoride PET. J Nucl Med 2019;60:530-5.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Rahim MK, Kim SE, So H, Kim HJ, Cheon GJ, Lee ES, et al. Recent trends in PET image interpretations using volumetric and texture-based quantification methods in nuclear oncology. Nucl Med Mol Imaging 2014;48:1-15.PubMedPubMedCentralCrossRef Rahim MK, Kim SE, So H, Kim HJ, Cheon GJ, Lee ES, et al. Recent trends in PET image interpretations using volumetric and texture-based quantification methods in nuclear oncology. Nucl Med Mol Imaging 2014;48:1-15.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Larson SM, Erdi Y, Akhurst T, Mazumdar M, Macapinlac HA, Finn RD, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging 1999;2:159-71.PubMedCrossRef Larson SM, Erdi Y, Akhurst T, Mazumdar M, Macapinlac HA, Finn RD, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging 1999;2:159-71.PubMedCrossRef
22.
Zurück zum Zitat Ahmadian A, Brogan A, Berman J, Sverdlov AL, Mercier G, Mazzini M, et al. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol 2014;21:925-39.PubMedCrossRef Ahmadian A, Brogan A, Berman J, Sverdlov AL, Mercier G, Mazzini M, et al. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol 2014;21:925-39.PubMedCrossRef
23.
Zurück zum Zitat Dey D, Schepis T, Marwan M, Slomka PJ, Berman DS, Achenbach S. Automated three-dimensional quantification of non-calcified coronary plaque from coronary CT angiography: Comparison with intravascular ultrasound. Radiology 2010;257:516-22.PubMedCrossRef Dey D, Schepis T, Marwan M, Slomka PJ, Berman DS, Achenbach S. Automated three-dimensional quantification of non-calcified coronary plaque from coronary CT angiography: Comparison with intravascular ultrasound. Radiology 2010;257:516-22.PubMedCrossRef
24.
Zurück zum Zitat Leipsic J, Abbara S, Achenbach S, Cury R, Earls JP, Mancini GJ, et al. SCCT guidelines for the interpretation and reporting of coronary CT angiography: A report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr 2014;8:342-58.PubMedCrossRef Leipsic J, Abbara S, Achenbach S, Cury R, Earls JP, Mancini GJ, et al. SCCT guidelines for the interpretation and reporting of coronary CT angiography: A report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr 2014;8:342-58.PubMedCrossRef
25.
Zurück zum Zitat Doris MK, Otaki Y, Krishnan SK, Kwiecinski J, Rubeaux M, Alessio A et al. Optimization of reconstruction and quantification of motion-corrected coronary PET-CT. J Nucl Cardiol 2018. Doris MK, Otaki Y, Krishnan SK, Kwiecinski J, Rubeaux M, Alessio A et al. Optimization of reconstruction and quantification of motion-corrected coronary PET-CT. J Nucl Cardiol 2018.
26.
Zurück zum Zitat Lassen ML, Kwiecinski J, Cadet S, Dey D, Wang C, Dweck MR, et al. Data-driven gross patient motion detection and compensation: Implications for coronary (18)F-NaF PET imaging. J Nucl Med 2019;60:830-6.PubMedPubMedCentralCrossRef Lassen ML, Kwiecinski J, Cadet S, Dey D, Wang C, Dweck MR, et al. Data-driven gross patient motion detection and compensation: Implications for coronary (18)F-NaF PET imaging. J Nucl Med 2019;60:830-6.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-32.PubMedCrossRef Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-32.PubMedCrossRef
28.
Zurück zum Zitat Arbab-Zadeh A, Fuster V. The Myth of the “Vulnerable Plaque”. Transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment. J Am Coll Cardiol 2015;65:846-55.PubMedPubMedCentralCrossRef Arbab-Zadeh A, Fuster V. The Myth of the “Vulnerable Plaque”. Transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment. J Am Coll Cardiol 2015;65:846-55.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Arbab-Zadeh A, Fuster V. From detecting the vulnerable plaque to managing the vulnerable patient: JACC state-of-the-art review. J Am Coll Cardiol 2019;74:1582-93.PubMedCrossRef Arbab-Zadeh A, Fuster V. From detecting the vulnerable plaque to managing the vulnerable patient: JACC state-of-the-art review. J Am Coll Cardiol 2019;74:1582-93.PubMedCrossRef
30.
Zurück zum Zitat Bellinge JW, Francis RJ, Majeed K, Watts GF, Schultz CJ. In search of the vulnerable patient or the vulnerable plaque: (18)F-sodium fluoride positron emission tomography for cardiovascular risk stratification. J Nucl Cardiol 2018;25:1774-83.PubMedCrossRef Bellinge JW, Francis RJ, Majeed K, Watts GF, Schultz CJ. In search of the vulnerable patient or the vulnerable plaque: (18)F-sodium fluoride positron emission tomography for cardiovascular risk stratification. J Nucl Cardiol 2018;25:1774-83.PubMedCrossRef
31.
Zurück zum Zitat Budoff MJ, Young R, Burke G, Jeffrey Carr J, Detrano RC, Folsom AR, et al. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: The multi-ethnic study of atherosclerosis (MESA). Eur Heart J 2018;39:2401-8.PubMedPubMedCentralCrossRef Budoff MJ, Young R, Burke G, Jeffrey Carr J, Detrano RC, Folsom AR, et al. Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: The multi-ethnic study of atherosclerosis (MESA). Eur Heart J 2018;39:2401-8.PubMedPubMedCentralCrossRef
32.
33.
Zurück zum Zitat Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: A report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2007;49:378-402.CrossRefPubMed Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: A report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2007;49:378-402.CrossRefPubMed
34.
Zurück zum Zitat Budoff MJ, Mayrhofer T, Ferencik M, Bittner D, Lee KL, Lu MT, et al. Prognostic value of coronary artery calcium in the PROMISE study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain). Circulation 2017;136:1993-2005.PubMedPubMedCentralCrossRef Budoff MJ, Mayrhofer T, Ferencik M, Bittner D, Lee KL, Lu MT, et al. Prognostic value of coronary artery calcium in the PROMISE study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain). Circulation 2017;136:1993-2005.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Erbel R, Mohlenkamp S, Moebus S, Schmermund A, Lehmann N, Stang A, et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: The Heinz Nixdorf Recall study. J Am Coll Cardiol 2010;56:1397-406.PubMedCrossRef Erbel R, Mohlenkamp S, Moebus S, Schmermund A, Lehmann N, Stang A, et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: The Heinz Nixdorf Recall study. J Am Coll Cardiol 2010;56:1397-406.PubMedCrossRef
36.
Zurück zum Zitat Doris M, Moss AJ, Andrews JPM, Williams M, Van Beek EJR, Forsyth L et al. Coronary 18F-sodium fluoride uptake predicts progression of coronary arterial calcification. Volume 40, Issue Supplement_1, October 2019, ehz747.0051. Doris M, Moss AJ, Andrews JPM, Williams M, Van Beek EJR, Forsyth L et al. Coronary 18F-sodium fluoride uptake predicts progression of coronary arterial calcification. Volume 40, Issue Supplement_1, October 2019, ehz747.0051.
37.
Zurück zum Zitat Kwiecinski J, Tzolos E, Adamson PD, Cadet S, Moss AJ, Joshi N et al. 18F-sodium fluoride coronary uptake predicts outcome in patients with coronary artery disease. JACC; 2020. Kwiecinski J, Tzolos E, Adamson PD, Cadet S, Moss AJ, Joshi N et al. 18F-sodium fluoride coronary uptake predicts outcome in patients with coronary artery disease. JACC; 2020.
Metadaten
Titel
Observer repeatability and interscan reproducibility of 18F-sodium fluoride coronary microcalcification activity
verfasst von
Evangelos Tzolos, MD
Jacek Kwiecinski, MD, PhD
Martin Lyngby Lassen, PhD
Sebastien Cadet, MS
Philip D. Adamson, MD, PhD
Alastair J. Moss, MD, PhD
Nikhil Joshi, MD, PhD
Michelle C. Williams, MD, PhD
Edwin J. R. van Beek, MD, PhD
Damini Dey, PhD
Daniel S. Berman, MD
Marc R. Dweck, MD, PhD
David E. Newby, MD, PhD
Piotr J. Slomka, PhD
Publikationsdatum
11.06.2020
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 1/2022
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-020-02221-1

Weitere Artikel der Ausgabe 1/2022

Journal of Nuclear Cardiology 1/2022 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.